233 related articles for article (PubMed ID: 28719392)
1. Intestinal microbiome in scleroderma: recent progress.
Volkmann ER
Curr Opin Rheumatol; 2017 Nov; 29(6):553-560. PubMed ID: 28719392
[TBL] [Abstract][Full Text] [Related]
2. Update on the Gastrointestinal Microbiome in Systemic Sclerosis.
Bellocchi C; Volkmann ER
Curr Rheumatol Rep; 2018 Jun; 20(8):49. PubMed ID: 29943234
[TBL] [Abstract][Full Text] [Related]
3. The microbiome and systemic sclerosis: A review of current evidence.
Tan TC; Noviani M; Leung YY; Low AHL
Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101687. PubMed ID: 33849778
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement.
Patrone V; Puglisi E; Cardinali M; Schnitzler TS; Svegliati S; Festa A; Gabrielli A; Morelli L
Sci Rep; 2017 Nov; 7(1):14874. PubMed ID: 29093509
[TBL] [Abstract][Full Text] [Related]
5. Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium.
Volkmann ER; Chang YL; Barroso N; Furst DE; Clements PJ; Gorn AH; Roth BE; Conklin JL; Getzug T; Borneman J; McGovern DP; Tong M; Jacobs JP; Braun J
Arthritis Rheumatol; 2016 Jun; 68(6):1483-92. PubMed ID: 26749064
[TBL] [Abstract][Full Text] [Related]
6. Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis.
Plichta DR; Somani J; Pichaud M; Wallace ZS; Fernandes AD; Perugino CA; Lähdesmäki H; Stone JH; Vlamakis H; Chung DC; Khanna D; Pillai S; Xavier RJ
Genome Med; 2021 Feb; 13(1):35. PubMed ID: 33648559
[TBL] [Abstract][Full Text] [Related]
7. Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease.
Andréasson K; Alrawi Z; Persson A; Jönsson G; Marsal J
Arthritis Res Ther; 2016 Nov; 18(1):278. PubMed ID: 27894337
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Aberration in Patients of Systemic Sclerosis and Bleomycin-Induced Mice Model.
Tang J; Zhou X; Wu X; Lin S; Ming B; Zhong J; Wang B; Dong L
Front Cell Infect Microbiol; 2021; 11():647201. PubMed ID: 34123867
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis and Gut Microbiota Modulation in Systemic Sclerosis.
Lemos MPC; Zucoloto TG; Oliveira MC; de Oliveira GLV
J Clin Rheumatol; 2022 Mar; 28(2):e568-e573. PubMed ID: 34030162
[TBL] [Abstract][Full Text] [Related]
10. Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts.
Volkmann ER; Hoffmann-Vold AM; Chang YL; Jacobs JP; Tillisch K; Mayer EA; Clements PJ; Hov JR; Kummen M; Midtvedt Ø; Lagishetty V; Chang L; Labus JS; Molberg Ø; Braun J
BMJ Open Gastroenterol; 2017; 4(1):e000134. PubMed ID: 28761687
[TBL] [Abstract][Full Text] [Related]
11. The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential.
Kim S; Park HJ; Lee SI
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555792
[TBL] [Abstract][Full Text] [Related]
12. Microbial and metabolic multi-omic correlations in systemic sclerosis patients.
Bellocchi C; Fernández-Ochoa Á; Montanelli G; Vigone B; Santaniello A; Milani C; Quirantes-Piné R; Borrás-Linares I; Ventura M; Segura-Carrettero A; Alarcón-Riquelme ME; Beretta L
Ann N Y Acad Sci; 2018 Jun; 1421(1):97-109. PubMed ID: 29749635
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome profiling in systemic sclerosis: a metagenomic approach.
Tan TC; Chandrasekaran L; Leung YY; Purbojati R; Pettersson S; Low AHL
Clin Exp Rheumatol; 2023 Aug; 41(8):1578-1588. PubMed ID: 36826808
[TBL] [Abstract][Full Text] [Related]
14. HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation.
Gootenberg DB; Paer JM; Luevano JM; Kwon DS
Curr Opin Infect Dis; 2017 Feb; 30(1):31-43. PubMed ID: 27922852
[TBL] [Abstract][Full Text] [Related]
15. Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.
Grigg JB; Sonnenberg GF
J Immunol; 2017 Jan; 198(2):564-571. PubMed ID: 28069751
[TBL] [Abstract][Full Text] [Related]
16. A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis.
Teaw S; Hinchcliff M; Cheng M
Rheumatology (Oxford); 2021 Dec; 60(12):5498-5508. PubMed ID: 33734316
[TBL] [Abstract][Full Text] [Related]
17. The gut microbiota and inflammatory bowel disease.
Goto Y; Kurashima Y; Kiyono H
Curr Opin Rheumatol; 2015 Jul; 27(4):388-96. PubMed ID: 26002031
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of fecal microbiota transplantation in the treatment of systemic sclerosis: A protocol for systematic review and meta analysis.
Zhang S; Lv J; Ren X; Hao X; Zhou P; Wang Y
Medicine (Baltimore); 2020 Jul; 99(28):e21267. PubMed ID: 32664182
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
Shahi SK; Freedman SN; Mangalam AK
Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
[TBL] [Abstract][Full Text] [Related]
20. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: a systematic review.
Rutayisire E; Huang K; Liu Y; Tao F
BMC Gastroenterol; 2016 Jul; 16(1):86. PubMed ID: 27475754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
